EMEA (Europe, Middle East and Africa) NGS-based RNA-seq Market Report 2018

Table of Contents

EMEA (Europe, Middle East and Africa) NGS-based RNA-seq Market Report 2018

1 NGS-based RNA-seq Overview

• 1.1 Product Overview and Scope of NGS-based RNA-seq
• 1.2 Classification of NGS-based RNA-seq
  • 1.2.1 EMEA NGS-based RNA-seq Market Size (Sales) Comparison by Type (2013-2025)
  • 1.2.2 EMEA NGS-based RNA-seq Market Size (Sales) Market Share by Type (Product Category) in 2017
  • 1.2.3 Sample Preparation
  • 1.2.4 Sample Preparation, by Method
  • 1.2.5 Sequencing Platforms & Consumables for RNA-Seq
  • 1.2.6 RNA Sequencing Services
  • 1.2.7 Data Analysis, Storage, and Management
• 1.3 EMEA NGS-based RNA-seq Market by Application/End Users
  • 1.3.1 EMEA NGS-based RNA-seq Sales (Volume) and Market Share Comparison by Application (2013-2025)
  • 1.3.2 De Novo Transcriptome Assembly
  • 1.3.3 Expression Profiling Analysis
  • 1.3.4 Variant Calling and Transcriptome Epigenetics
  • 1.3.5 Small RNA Sequencing
• 1.4 EMEA NGS-based RNA-seq Market by Region
  • 1.4.1 EMEA NGS-based RNA-seq Market Size (Value) Comparison by Region (2013-2025)
  • 1.4.2 Europe Status and Prospect (2013-2025)
  • 1.4.3 Middle East Status and Prospect (2013-2025)
  • 1.4.4 Africa Status and Prospect (2013-2025)
• 1.5 EMEA Market Size (Value and Volume) of NGS-based RNA-seq (2013-2025)
  • 1.5.1 EMEA NGS-based RNA-seq Sales and Growth Rate (2013-2025)
  • 1.5.2 EMEA NGS-based RNA-seq Revenue and Growth Rate (2013-2025)

2 EMEA NGS-based RNA-seq Competition by Manufacturers/Players/Suppliers, Region, Type and Application

• 2.1 EMEA NGS-based RNA-seq Market Competition by Players/Manufacturers
  • 2.1.1 EMEA NGS-based RNA-seq Sales Volume and Market Share of Major Players (2013-2018)
  • 2.1.2 EMEA NGS-based RNA-seq Revenue and Share by Players (2013-2018)
  • 2.1.3 EMEA NGS-based RNA-seq Sale Price by Players (2013-2018)
• 2.2 EMEA NGS-based RNA-seq (Volume and Value) by Type/Product Category
  • 2.2.1 EMEA NGS-based RNA-seq Sales and Market Share by Type (2013-2018)
  • 2.2.2 EMEA NGS-based RNA-seq Revenue and Market Share by Type (2013-2018)
  • 2.2.3 EMEA NGS-based RNA-seq Sale Price by Type (2013-2018)
• 2.3 EMEA NGS-based RNA-seq (Volume) by Application
• 2.4 EMEA NGS-based RNA-seq (Volume and Value) by Region
  • 2.4.1 EMEA NGS-based RNA-seq Sales and Market Share by Region (2013-2018)
  • 2.4.2 EMEA NGS-based RNA-seq Revenue and Market Share by Region (2013-2018)
  • 2.4.3 EMEA NGS-based RNA-seq Sales Price by Region (2013-2018)

3 Europe NGS-based RNA-seq (Volume, Value and Sales Price), by Players, Countries, Type and Application

• 3.1 Europe NGS-based RNA-seq Sales and Value (2013-2018)
  • 3.1.1 Europe NGS-based RNA-seq Sales Volume and Growth Rate (2013-2018)
  • 3.1.2 Europe NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
• 3.2 Europe NGS-based RNA-seq Sales and Market Share by Type
• 3.3 Europe NGS-based RNA-seq Sales and Market Share by Application
• 3.4 Europe NGS-based RNA-seq Sales Volume and Value (Revenue) by Countries
  • 3.4.1 Europe NGS-based RNA-seq Sales Volume by Countries (2013-2018)
  • 3.4.2 Europe NGS-based RNA-seq Revenue by Countries (2013-2018)
  • 3.4.3 Germany NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 3.4.4 France NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 3.4.5 UK NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 3.4.6 Russia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 3.4.7 Italy NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 3.4.8 Benelux NGS-based RNA-seq Sales and Growth Rate (2013-2018)

4 Middle East NGS-based RNA-seq (Volume, Value and Sales Price), by Region, Type and Application

• 4.1 Middle East NGS-based RNA-seq Sales and Value (2013-2018)
  • 4.1.1 Middle East NGS-based RNA-seq Sales Volume and Growth Rate (2013-2018)
  • 4.1.2 Middle East NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
• 4.2 Middle East NGS-based RNA-seq Sales and Market Share by Type
• 4.3 Middle East NGS-based RNA-seq Sales and Market Share by Application
• 4.4 Middle East NGS-based RNA-seq Sales Volume and Value (Revenue) by Countries
  • 4.4.1 Middle East NGS-based RNA-seq Sales Volume by Countries (2013-2018)
  • 4.4.2 Middle East NGS-based RNA-seq Revenue by Countries (2013-2018)
  • 4.4.3 Saudi Arabia NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 4.4.4 Israel NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 4.4.5 UAE NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 4.4.6 Iran NGS-based RNA-seq Sales and Growth Rate (2013-2018)

5 Africa NGS-based RNA-seq (Volume, Value and Sales Price) by Players, Countries, Type and Application

• 5.1 Africa NGS-based RNA-seq Sales and Value (2013-2018)
  • 5.1.1 Africa NGS-based RNA-seq Sales Volume and Growth Rate (2013-2018)
  • 5.1.2 Africa NGS-based RNA-seq Revenue and Growth Rate (2013-2018)
• 5.2 Africa NGS-based RNA-seq Sales and Market Share by Type
• 5.3 Africa NGS-based RNA-seq Sales and Market Share by Application
• 5.4 Africa NGS-based RNA-seq Sales Volume and Value (Revenue) by Countries
  • 5.4.1 Africa NGS-based RNA-seq Sales Volume by Countries (2013-2018)
  • 5.4.2 Africa NGS-based RNA-seq Revenue by Countries (2013-2018)
  • 5.4.3 South Africa NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 5.4.4 Nigeria NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 5.4.5 Egypt NGS-based RNA-seq Sales and Growth Rate (2013-2018)
  • 5.4.6 Algeria NGS-based RNA-seq Sales and Growth Rate (2013-2018)

6 EMEA NGS-based RNA-seq Manufacturers/Players Profiles and Sales Data

• 6.1 Illumina
  • 6.1.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.1.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.1.2.1 Product A
    • 6.1.2.2 Product B
  • 6.1.3 Illumina NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.1.4 Main Business/Business Overview
• 6.2 Thermo Fisher Scientific
  • 6.2.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.2.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.2.2.1 Product A
    • 6.2.2.2 Product B
  • 6.2.3 Thermo Fisher Scientific NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.2.4 Main Business/Business Overview
• 6.3 Pacific Biosciences of California
  • 6.3.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.3.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.3.2.1 Product A
    • 6.3.2.2 Product B
  • 6.3.3 Pacific Biosciences of California NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.3.4 Main Business/Business Overview
• 6.4 QIAGEN
  • 6.4.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.4.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.4.2.1 Product A
    • 6.4.2.2 Product B
  • 6.4.3 QIAGEN NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.4.4 Main Business/Business Overview
• 6.5 BGI
  • 6.5.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.5.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.5.2.1 Product A
    • 6.5.2.2 Product B
  • 6.5.3 BGI NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.5.4 Main Business/Business Overview
• 6.6 Oxford Nanopore Technologies
  • 6.6.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.6.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.6.2.1 Product A
    • 6.6.2.2 Product B
  • 6.6.3 Oxford Nanopore Technologies NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.6.4 Main Business/Business Overview
• 6.7 PerkinElmer
  • 6.7.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.7.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.7.2.1 Product A
    • 6.7.2.2 Product B
  • 6.7.3 PerkinElmer NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.7.4 Main Business/Business Overview
• 6.8 GATC Biotech
  • 6.8.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.8.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.8.2.1 Product A
    • 6.8.2.2 Product B
  • 6.8.3 GATC Biotech NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.8.4 Main Business/Business Overview
• 6.9 Agilent Technologies
  • 6.9.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.9.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.9.2.1 Product A
    • 6.9.2.2 Product B
  • 6.9.3 Agilent Technologies NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.9.4 Main Business/Business Overview
• 6.10 Roche
  • 6.10.1 Company Basic Information, Manufacturing Base and Competitors
  • 6.10.2 NGS-based RNA-seq Product Type, Application and Specification
    • 6.10.2.1 Product A
    • 6.10.2.2 Product B
  • 6.10.3 Roche NGS-based RNA-seq Sales, Revenue, Price and Gross Margin (2013-2018)
  • 6.10.4 Main Business/Business Overview
• 6.11 Macrogen
• 6.12 Eurofins Scientific

7 NGS-based RNA-seq Manufacturing Cost Analysis

• 7.1 NGS-based RNA-seq Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Price Trend of Key Raw Materials
  • 7.1.3 Key Suppliers of Raw Materials
  • 7.1.4 Market Concentration Rate of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
  • 7.2.1 Raw Materials
  • 7.2.2 Labor Cost
  • 7.2.3 Manufacturing Expenses
• 7.3 Manufacturing Process Analysis of NGS-based RNA-seq

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

• 8.1 NGS-based RNA-seq Industrial Chain Analysis
• 8.2 Upstream Raw Materials Sourcing
• 8.3 Raw Materials Sources of NGS-based RNA-seq Major Manufacturers in 2017
• 8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
  • 9.1.3 Marketing Channel Development Trend
• 9.2 Market Positioning
  • 9.2.1 Pricing Strategy
  • 9.2.2 Brand Strategy
  • 9.2.3 Target Client
• 9.3 Distributors/Traders List

10 Market Effect Factors Analysis

• 10.1 Technology Progress/Risk
  • 10.1.1 Substitutes Threat
  • 10.1.2 Technology Progress in Related Industry
• 10.2 Consumer Needs/Customer Preference Change
• 10.3 Economic/Political Environmental Change

11 EMEA NGS-based RNA-seq Market Forecast (2018-2025)

• 11.1 EMEA NGS-based RNA-seq Sales, Revenue and Price Forecast (2018-2025)
  • 11.1.1 EMEA NGS-based RNA-seq Sales and Growth Rate Forecast (2018-2025)
  • 11.1.2 EMEA NGS-based RNA-seq Revenue and Growth Rate Forecast (2018-2025)
  • 11.1.3 EMEA NGS-based RNA-seq Price and Trend Forecast (2018-2025)
• 11.2 EMEA NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
• 11.3 Europe NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
• 11.4 Middle Eastt NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
• 11.5 Africa NGS-based RNA-seq Sales, Revenue and Growth Rate Forecast by Region (2018-2025)
• 11.6 EMEA NGS-based RNA-seq Sales Forecast by Type (2018-2025)
• 11.7 EMEA NGS-based RNA-seq Sales Forecast by Application (2018-2025)

12 Research Findings and Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources